I

Illumina

Leading DNA Sequencing Technology

San Diego, CA
10,000+

About Illumina

Industry: Genomics
Founded: 1998
Founders: David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, Mark Chee
Status: Public (NASDAQ: ILMN)

Funding & Growth

Total Raised: N/A
Valuation: $20B+ market cap
Stage: Public
Key Investors:
Public markets

Pros

  • Industry leader in sequencing technology
  • Cutting-edge genomics work
  • Strong publication culture
  • Excellent benefits and RSUs
  • San Diego location

Cons

  • Large company bureaucracy
  • Recent layoffs and restructuring
  • Can be siloed between teams
  • Slower decision making

🏢 Working Here

At Illumina, bioinformaticians work at the intersection of cutting-edge sequencing technology and large-scale genomic data analysis.

Teams are organized around product lines (NovaSeq, MiSeq, BaseSpace) and research areas (oncology, reproductive health, population genomics).

A typical day involves developing and optimizing analysis pipelines, collaborating with wet-lab scientists, and pushing the boundaries of what's computationally possible with sequencing data.

The DRAGEN team, responsible for Illumina's ultra-fast secondary analysis platform, is particularly prestigious.

Work-life balance is generally good, with flexible hours and remote work options.

San Diego's biotech community creates excellent networking opportunities, and Illumina's publication-friendly culture means your work often contributes to high-impact papers.

🧬 Bioinformatics Focus

Illumina's bioinformatics focus spans the entire genomics pipeline. Key areas include:

  • Secondary analysis algorithms - variant calling, alignment, base calling improvements for NovaSeq instruments,
  • DRAGEN acceleration - FPGA-based genomics pipeline achieving 30x speedups,
  • BaseSpace platform - cloud-based analysis workflows and app ecosystem,
  • Machine learning for instrument QC and error correction,
  • Population - scale genomics - analyzing datasets with millions of samples. Notable projects include the All of Us Research Program, UK Biobank sequencing, and cancer genomics partnerships with major medical centers. Technical challenges involve handling petabyte-scale data, optimizing for accuracy vs. speed tradeoffs, and developing methods for novel sequencing applications like single-cell and spatial transcriptomics.

📈 Career Growth & Development

Career Paths

Scientist Track

Scientist I Scientist II Senior Scientist Principal Scientist Distinguished Scientist

Software Engineering Track

SWE I SWE II SWE III SWE IV SWE V
💰

Compensation

Stock refreshes and bonuses increase significantly at Senior+ levels. Compensation is competitive.

📚

Development

Illumina invests heavily in professional development through tuition reimbursement, conference attendance, and internal seminars.

🔄

Mobility

Transitioning between wet-lab and computational roles is possible. Many alumni move to leadership roles at startups or academic positions.

🏆

Growth

Scientist I roles typically require PhD + 0-2 years; progression to Scientist II takes 2-3 years with demonstrated impact. Senior Scientist requires 5-7 years total experience, while Principal level demands 10+ years.